<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BC926EAB-A44D-4439-B901-7437B838066F"><gtr:id>BC926EAB-A44D-4439-B901-7437B838066F</gtr:id><gtr:firstName>Lesley</gtr:firstName><gtr:surname>Fallowfield</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1C19F7AF-5A4B-4B2D-A649-3A45425290A4"><gtr:id>1C19F7AF-5A4B-4B2D-A649-3A45425290A4</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Jacobs</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0000735"><gtr:id>EFA9F92C-783E-4F8A-B163-D7EA18C8D8BB</gtr:id><gtr:title>UKCTOCS Psychosocial Study Extension</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0000735</gtr:grantReference><gtr:abstractText>The feasibility of introducing a National Ovarian Cancer Screening programme similar to that offered to women for breast cancer, together with measurement of the procedure?s impact on morbidity and mortality is being supported by the MRC. We are conducting the Quality of Life and psychosocial impact of the screening study and to date have more than 187,000 women enrolled.</gtr:abstractText><gtr:technicalSummary>The research questions being addressed by the Psychosocial arm of the UKCTOCS study are:
1. To examine the knowledge, beliefs and attitudes of women in a general population sample to ovarian cancer screening.
2. To investigate the effect of different screening procedures on women?s anxiety, depression and sexual functioning.
3. To examine women?s perception of ovarian cancer risk and the impact that this has on willingness to attend for screening and subsequent compliance.
4. To compare women?s satisfaction with, and acceptability of, the different screening procedures.</gtr:technicalSummary><gtr:fund><gtr:end>2011-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1382234</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Ovarian Cancer Mortality Results Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4D44AF19-8DE3-4AC8-BE36-96C4B6AAB0AE</gtr:id><gtr:impact>Public Meeting held on the morning of 17th December 2015 with a session on Psycho Social sub-study results presented by Professor Dame Lesley Fallowfield. The public meeting was attended by participating researchers, patient representatives, press and other interested parties who registered in advance and was also broadcast live on the web. See the live link below to view the meeting. The public meeting was reported widely by the press including the BBC, ITV, New York Times, Daily Mail, France 24 and others.</gtr:impact><gtr:outcomeId>56b0d06d57d6c6.51340292</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/live/ukctocs</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6BEF1C61-A2DE-4CF0-8D5E-8F8DA410F743</gtr:id><gtr:title>Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05c6525a00e9dfbcaa3a5211fbcf467"><gtr:id>f05c6525a00e9dfbcaa3a5211fbcf467</gtr:id><gtr:otherNames>Jacobs I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>LdYxmmp9owe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>073ABDC0-B140-47D2-BC11-941418726D0C</gtr:id><gtr:title>The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5437a6f69334797e7de5165b0ad10976"><gtr:id>5437a6f69334797e7de5165b0ad10976</gtr:id><gtr:otherNames>Menon U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5a78724f042d46.39157624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27D5CE3A-8754-425B-9BC3-123DB36E4357</gtr:id><gtr:title>Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5437a6f69334797e7de5165b0ad10976"><gtr:id>5437a6f69334797e7de5165b0ad10976</gtr:id><gtr:otherNames>Menon U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>D26F0679C80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FE262BB-B405-4D79-BB72-30AF4207DF25</gtr:id><gtr:title>Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5437a6f69334797e7de5165b0ad10976"><gtr:id>5437a6f69334797e7de5165b0ad10976</gtr:id><gtr:otherNames>Menon U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>58a480b4038ca3.47947294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26B3FBBB-AFA5-4080-8800-502CD44A0CFA</gtr:id><gtr:title>The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4427bd0ed7bc34790b20866189c16d15"><gtr:id>4427bd0ed7bc34790b20866189c16d15</gtr:id><gtr:otherNames>Fallowfield L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5a35cdd86a1c65.49220088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD0106D2-C152-4254-BF9C-C8B1846EEFAE</gtr:id><gtr:title>Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5437a6f69334797e7de5165b0ad10976"><gtr:id>5437a6f69334797e7de5165b0ad10976</gtr:id><gtr:otherNames>Menon U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>569e21e87c1ad3.06881104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6A15DBC-1A1B-47AA-BB12-29820C9A2989</gtr:id><gtr:title>Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening.</gtr:title><gtr:parentPublicationTitle>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3d9fcac32bedd45dca8329d4ad63648"><gtr:id>c3d9fcac32bedd45dca8329d4ad63648</gtr:id><gtr:otherNames>Jenkins V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1048-891X</gtr:issn><gtr:outcomeId>569e2162c51ad0.37752706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBF75399-39DD-4BB2-BF57-5DF25C4F46A1</gtr:id><gtr:title>Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5437a6f69334797e7de5165b0ad10976"><gtr:id>5437a6f69334797e7de5165b0ad10976</gtr:id><gtr:otherNames>Menon U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>C4559B9C348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A12A5AEC-C1C3-405F-A9B3-AAF38CFFA48B</gtr:id><gtr:title>Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05c6525a00e9dfbcaa3a5211fbcf467"><gtr:id>f05c6525a00e9dfbcaa3a5211fbcf467</gtr:id><gtr:otherNames>Jacobs I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>569e20edbf94d3.26924508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E079803B-8461-4D86-ADF9-235F529B3A20</gtr:id><gtr:title>Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39766f2c58c53463ac157701e94718"><gtr:id>cf39766f2c58c53463ac157701e94718</gtr:id><gtr:otherNames>Burnell M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>L2HYB68yUct</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CDE0E9E-5A71-4D3B-9724-8EE53A1923DD</gtr:id><gtr:title>Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.</gtr:title><gtr:parentPublicationTitle>Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b05c8f22e6815a1f325e5514637fea3"><gtr:id>4b05c8f22e6815a1f325e5514637fea3</gtr:id><gtr:otherNames>Gentry-Maharaj A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-7692</gtr:issn><gtr:outcomeId>pm_13585_25_22791597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>437ACF6F-27FC-4790-9B13-24D1BFDF5BBB</gtr:id><gtr:title>Ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Disease primers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39f68e08c4aaa24ec3a817da328ce58d"><gtr:id>39f68e08c4aaa24ec3a817da328ce58d</gtr:id><gtr:otherNames>Matulonis UA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2056-676X</gtr:issn><gtr:outcomeId>58a480b3c46723.11783607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7196B2E5-E7B7-4E17-901A-B697095EC757</gtr:id><gtr:title>Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/746d6e4c7a1e8580f69066c5c55eb1b5"><gtr:id>746d6e4c7a1e8580f69066c5c55eb1b5</gtr:id><gtr:otherNames>Barrett J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>544674f3f29852.71744297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A50969E5-0D78-41E7-A60F-882CA8805DC6</gtr:id><gtr:title>Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4427bd0ed7bc34790b20866189c16d15"><gtr:id>4427bd0ed7bc34790b20866189c16d15</gtr:id><gtr:otherNames>Fallowfield L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>VVneaUQLoxw</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0000735</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>